In addition, it has been suggested that the earliest appearance of tau pathology in AD occurs in the locus caeruleus instead of hippocampus [21], which could account for the lack of p-tau immnunoreactivity in hippocampal samples from our cohort of patients with AD. This evidence concerns the gene MAPT and Alzheimer disease.